7 Essential Steps When Your Ulcerative Colitis Treatment Isn’t Working

Ulcerative colitis (UC) is characterized by alternating flare‑ups and periods of remission. While no medication cures UC, the right therapy can shorten flares and reduce their frequency.

Occasionally a drug that once worked may lose its effectiveness, or it may never have been the best match for your disease pattern. If you’re still experiencing frequent or severe flares, consider the seven evidence‑based actions below to regain control.

Understanding the purpose and delivery method of each medication class helps you have a more productive conversation with your gastroenterologist.

Aminosalicylates (5‑ASA drugs)

These agents are the first‑line choice for mild to moderate UC because they target inflammation directly in the colon.

They can be administered:

• Orally (tablet or capsule)
• Rectally as an enema
• Rectally as a suppository

Common brand names include:

• Mesalamine (Apriso, Canasa)
• Olsalazine (Dipentum)
• Balsalazide (Colazal)

Corticosteroids

Corticosteroids are reserved for moderate to severe flares. They work quickly but are intended for short‑term use due to risks such as weight gain, bone loss, and glucose intolerance.

Formulations range from topical (foam, suppository) to systemic (pill, syrup, IV). Oral steroids are more potent but carry a higher side‑effect burden.

Examples include:

• Budesonide (Uceris)
• Prednisone (Prednisone Intensol, Rayos)
• Prednisolone (Prelone)
• Methylprednisolone (Medrol, Depo‑Medrol)

Immunosuppressants

If 5‑ASA agents and steroids do not achieve remission, your doctor may add an immunosuppressant to dampen the immune response that damages the colon.

These drugs are available as oral tablets, liquid suspensions, or injectables. Although the FDA has not formally approved them for UC, many gastroenterologists prescribe them off‑label when clinical experience supports benefit.

Typical agents are:

• Methotrexate (Trexall, Otrexup, Rasuvo)
• Azathioprine (Azasan, Imuran)
• Tacrolimus (Astagraf XL, Envarsus XR, Prograf)

Biologics

Biologic therapies are indicated for moderate to severe UC that is refractory to the above classes. They target specific proteins in the inflammatory cascade, offering a more precise suppression of disease activity.

Administration is either intravenous infusion or subcutaneous injection. Brand‑specific names were omitted in the source; clinicians will select the most appropriate agent based on disease phenotype and prior response.

Tofacitinib

Tofacitinib is a Janus kinase (JAK) inhibitor that functions similarly to biologics by blocking inflammatory signaling pathways. It is available as a tablet or oral solution under the names Xeljanz and Xeljanz XR.

Because UC management is a long‑term commitment, adherence is critical. Missing doses or stopping medication abruptly can trigger a flare.

When you receive a new prescription, confirm the dosing schedule with your pharmacist. If a dose is missed, contact your provider promptly for guidance.

Should side effects arise, schedule a visit rather than discontinuing the drug on your own.

Monitor Symptoms Closely

A flare may present dramatically (abdominal pain, bloody diarrhea) or subtly (increased stool frequency, fatigue, weight loss). Keep a daily symptom diary and share it with your doctor, noting:

• Changes in bowel frequency or consistency
• Visible blood in stool
• Unexplained fatigue or low energy
• Reduced appetite or weight loss
• Extra‑intestinal manifestations (joint pain, mouth ulcers)

Documenting even minor variations helps your clinician adjust therapy before a full‑blown flare develops.

Combination Therapy

In refractory cases, two agents may be prescribed together—for example, a biologic combined with an immunosuppressant. While this strategy can boost efficacy, it also raises the risk of infections and other adverse events. Your physician will weigh benefits against potential harms.

When to Escalate Treatment

If flares become more frequent or severe, discuss the following options with your gastroenterologist:

• Switching to a different formulation of the same drug (e.g., from an enema to an oral 5‑ASA)
• Introducing a short course of corticosteroids for rapid control
• Transitioning to a biologic or JAK inhibitor

Dietary Adjustments

While no diet cures UC, certain foods can exacerbate symptoms. Consider limiting or avoiding:

• Dairy products
• Caffeinated beverages (coffee, tea, sodas)
• Alcohol
• Fruit and fruit juices
• Fried or high‑fat foods
• Spices and heavily seasoned dishes
• High‑fiber items (whole‑grain breads, legumes, cruciferous vegetables like broccoli or cabbage)
• Red meats (steak, burgers)
• Popcorn, peanuts, artificial colors and sweeteners

A food diary can pinpoint personal triggers.

Surgical Options

When medication and lifestyle measures fail, surgery may be required. The most common procedure is the ileal pouch‑anal anastomosis (J‑pouch). It removes the colon and rectum and creates an internal reservoir for waste, eliminating the need for a permanent ostomy.

Post‑operative adaptation can take weeks to months, but many patients achieve long‑term remission. It’s important to understand that extra‑intestinal manifestations (e.g., joint pain, skin issues) may persist because UC is an immune‑mediated disease.

In rare cases, inflammation may shift to the small intestine after surgery, prompting a re‑classification to Crohn’s disease.

Ongoing Management

Treating UC often involves trial and error. Regular follow‑up appointments, diligent symptom tracking, and open communication with your care team are essential for optimal outcomes.

The more informed you are about your disease and the more consistently you follow the prescribed plan, the greater your chance of maintaining remission.